Idebenone in Friedreich ataxia and Leber’s hereditary optic neuropathy: close mechanisms, similar therapy?: Table 1

Persistence of the treatment effect of idebenone in Leber’s hereditary optic neuropathy

(2013) T. Klopstock et al.   BRAIN

Uncommon Leber “Plus” Disease Associated With Mitochondrial Mutation m.11778G>A in a Premature Child

(2013) Stéphanie Paquay et al.   JOURNAL OF CHILD NEUROLOGY

Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)

(2011) Sarah J. Lagedrost et al.   AMERICAN HEART JOURNAL

Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

(2011) Thomas Meier et al.   JOURNAL OF NEUROLOGY

NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels

(2011) Roman H. Haefeli et al.   PLoS One

A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia

(2010) David R. Lynch et al.   ARCHIVES OF NEUROLOGY

Exercise Capacity and Idebenone Intervention in Children and Adolescents With Friedreich Ataxia

(2010) Bart E. Drinkard et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Intermediate-Dose Idebenone and Quality of Life in Friedreich Ataxia

(2010) John F. Brandsema et al.   PEDIATRIC NEUROLOGY

Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy

(2009) C. Rinaldi et al.   JOURNAL OF NEUROLOGY

Visual system involvement in patients with Friedreich's ataxia

(2008) Filippo Fortuna et al.   BRAIN

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up

(2008) Mercè Pineda et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY